Facebook
Twitter
LinkedIn
ForwardWebinar: Understanding The Evidence: New Technologies For Treating BPH & LUTS (2020)
Course Director: Peter J. Gilling, MD
This course will assist Urologists and Allied staff in understanding the evidence-base and the clinical role of the newly-introduced techniques for treating BPH and LUTs. The technology behind each will be reviewed and the quality of the data supporting each will be examined with emphasis placed on the Pivotal trials and their methodology. The current Guidelines will be reviewed and a practical discussion of the peri-operative considerations and tips and tricks for the use of each will be covered.
Please note this course is FREE to all AUA Members and is an exclusive member benefit. If you would like to become an AUA Member, we'd be happy to have you - think about all the great member benefits!
Target Audience
- Urologists
- Residents
- Advanced Practice Providers (Nurse Practitioners and Physician Assistants)
Learning Objectives
Upon completion of this activity, participants will be able to:
- Differentiate between each of the new technologies for treating BPH/LUTS both based on mode-of-action and the quality of supporting evidence.
- Describe the features expected of a Pivotal Trial for BPH Medical Devices and be able to compare and contrast the findings of these trials for each of the current devices.
- Discuss the evidence base for current technologies, including pivotal studies, and be able to define the role and clinical expectation for each
- Interpret the current clinical results and the patient experiences of these treatments in relation to more established and even abandoned treatments for patient groups with similar characteristics.
- Cite and describe treatments undergoing development for BPH/LUTS.
Scientific Agenda
5:00 pm Welcome & Housekeeping
AUA
5:03 pm Overview
Peter Gilling, MBChB, MD, FRACS
Urology Bay of Plenty Limited, Tauranga and Grace Hospitals, New Zealand
5:10 pm Pivotal Trials for BPH, Rezum and PAE
Dean Elterman, MD, MSc, FRCSC, University of Toronto
5:25 pm Enucleation - Laser and Electrocautery
Michael S. Borofsky, MD
University of Minnesota
5:40 pm Aquablation and New Stents for BPH
Peter Gilling
5:55 pm Ejaculation and BPH treatments, Urolift & Future treatments
Henry Woo, MD
University of Sydney, Australia
6:10 pm Q&A
All Faculty
6:25 pm Wrap Up/Reminders
AUA
Understanding the Evidence: New Technologies For Treating BPH & LUTS (2020) will be held virtually on Wednesday, June 24 at 5 PM EST.
***Instructions***
- Click the "Register" tab.
- If prompted, click “update your profile”. Otherwise, click “Take Course”.
- Click “Start” under Live Webinar in the Course Progress pane.
- Click "Join Webinar".
Education Council Disclosures
EC Disclosures _June 1 20 through Dec 31 20_1.pdf
AUA Office of Education Staff has nothing to disclose.
Peter Gilling, MD
Michael Borofsky, MD
Dean Elterman, MD
Henry Woo, MD,FACS
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA Participant Information and Policies
DISCLAIMER:
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:
The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.
REPRODUCTION PERMISSION:
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
SPECIAL ASSISTANCE/DIETARY NEEDS:
The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation